Add BrightSurf on Google Email

Orforglipron taken orally once daily leads to significant body weight loss (ATTAIN-1 Study)

A phase 3 trial of once-daily orforglipron found substantial weight loss in people with obesity but not type 2 diabetes. The medication improved cardiometabolic levels and was associated with significant reductions in body weight, waist circumference, systolic blood pressure, triglyceride levels, and non-HDL cholesterol.

SourceEuropean Association for the Study of Diabetes·JournalNew England Journal of Medicine·DateSep 16, 2025

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

A study of individuals taking Ozempic, Wegovy, or Mounjaro found that 21.3% reported food tasting sweeter, while 22.6% said it tasted saltier than before. These changes were linked to reduced appetite and weight loss in all groups, with participants who experienced increased sweetness being twice as likely to report increased satiety.

SourceEuropean Association for the Study of Diabetes·JournalDiabetes Obesity and Metabolism·DateSep 15, 2025

Study points out that a synthetic molecule helps reduce visceral fat and improve sleep

A synthetic molecule called Pep19 has been shown to reduce visceral fat and improve sleep quality in overweight adults, with no side effects observed. The study involved 24 volunteers who took either a placebo or Pep19 in capsules, and found a 17% reduction in visceral fat and improved sleep quality in those who received the molecule.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalDiabetes/Metabolism Research and Reviews·DateAug 28, 2025

Teens with higher blood levels of PFAS regain more weight after bariatric surgery, study finds

A new study found that adolescents with higher blood levels of per- and polyfluoroalkyl substances (PFAS) prior to bariatric surgery regained more weight and had greater increases in waist circumference up to five years after surgery. Researchers believe PFAS exposure disrupts endocrine and metabolic processes, leading to weight regain.

SourceKeck School of Medicine of USC·JournalObesity·TypeMeta-analysis·DateAug 14, 2025

Lifestyle interventions reshape gene regulation in skeletal muscle of Asians

Researchers from NUS have tracked changes in gene expression and splicing patterns in skeletal muscle after a 16-week lifestyle intervention program involving supervised exercise and dietary changes. The study found that participants lost weight and improved insulin sensitivity, with specific genes showing evidence of G x L interaction.

SourceNational University of Singapore·JournalCell Genomics·TypeRandomized controlled/clinical trial·DateAug 1, 2025

Health: Anti-obesity medications associated with weight rebound post-treatment

A meta-analysis published in BMC Medicine found that patients prescribed anti-obesity medications may experience a significant weight gain after stopping their prescription. The study analyzed data from 11 randomised trials and suggests that six approved anti-obesity medications are associated with weight regain after treatment cessation.

SourceBMC (BioMed Central)·JournalBMC Medicine·TypeMeta-analysis·DateJul 21, 2025

Prescription weight loss medication linked to disordered eating behaviors in boys and men

A recent study of 1,543 males aged 15 to 35 found that those who used prescription weight loss medications reported significantly higher levels of disordered eating behaviors and attitudes. The study suggests that boys and men may face unique pressures or vulnerabilities related to body image and weight control, highlighting the need f...

SourceUniversity of Toronto·JournalEating Behaviors·DateJul 10, 2025

Adipose-derived stem cells remember obesity – anti-inflammatory capacity restored only years after weight loss

Recent research reveals that adipose-derived stem cells from obese individuals do not fully recover their anti-inflammatory capacity even two to three years after significant weight loss. The study, published in Stem Cells International, used bariatric surgery as a model to investigate the impact of weight loss on these stem cells.

SourceTampere University·JournalStem Cells International·DateJun 25, 2025

American College of Cardiology issues guidance on weight management drugs

The American College of Cardiology has issued a Concise Clinical Guidance document to inform clinicians about medication for weight management in patients with cardiovascular benefit. Modern obesity medications, such as semaglutide and tirzepatide, have been proven effective in reducing overall cardiovascular disease risk.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateJun 20, 2025

Intensive weight loss programme improves eating disorder symptoms in people with Type 2 Diabetes at risk of eating disorders, Oxford study finds

A University of Oxford study found that an intensive low-energy diet programme significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight at risk of developing eating disorders. The programme showed benefits persisting six months after completion.

SourceUniversity of Oxford·JournalThe Lancet Psychiatry·DateJun 10, 2025

Tufts chemists design a next generation of weight loss drugs

Researchers at Tufts University have designed a new compound that incorporates structural elements of four hormones - GLP-1, GIP, glucagon, and PYY - to create a single weight loss drug. This chimera peptide aims to address the drawbacks of current weight loss drugs, such as nausea and limited efficacy.

SourceTufts University·JournalJournal of the American Chemical Society·TypeExperimental study·DateJun 10, 2025

Cleveland Clinic research finds injectable medications for obesity produce smaller weight loss in a real-world setting, compared to randomized clinical trials

A Cleveland Clinic study found that patients taking injectable GLP-1 medications for obesity lost an average of 3.6% body weight, significantly lower than the 11.9% seen in non-discontinuers. Treatment discontinuation negatively impacted blood sugar control in those with prediabetes.

SourceCleveland Clinic·JournalObesity·DateJun 10, 2025

Adopting a healthy diet may have cardiometabolic benefits regardless of weight loss

A new study found that nearly one-third of individuals adopting healthy diets didn't lose weight but still experienced significant improvements in cardiometabolic markers, including increased HDL cholesterol and reduced visceral fat. The research suggests a healthy diet can have benefits beyond weight loss.

SourceHarvard T.H. Chan School of Public Health·JournalEuropean Journal of Preventive Cardiology·TypeRandomized controlled/clinical trial·DateJun 5, 2025

Weight-loss surgery in jeopardy

Bariatric surgery, a critical tool for combating obesity, is under threat in Australia due to skyrocketing indemnity insurance premiums. The study found that surgeons are being penalized by rising premiums, forcing some to reconsider their future in the field.

SourceFlinders University·JournalANZ Journal of Surgery·TypeSurvey·DateMay 18, 2025

Differences in weight loss among ethnicities points to need to look at socio-economic issues, York University study suggests

A new study by York University suggests that the broad ethnic categories used in clinical settings may mask differences in sub-ethnic groups. The findings indicate that socio-economic factors play a significant role in weight loss disparities among Black, Middle Eastern, Latin, and South Asian communities.

SourceYork University·JournalClinical Obesity·TypeData/statistical analysis·DateMay 14, 2025